MLMAX | RNPHX | MLMAX / RNPHX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 9 years | - |
Gain YTD | 4.679 | 4.639 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 40.9M | 148B | 0% |
Annual Yield % from dividends | 0.39 | 1.00 | 39% |
Returns for 1 year | 17.74 | 10.58 | 168% |
Returns for 3 years | 34.92 | 14.84 | 235% |
Returns for 5 years | 59.83 | 34.72 | 172% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
KDHAX | 56.44 | -0.07 | -0.12% |
DWS CROCI Equity Dividend A | |||
GQGPX | 16.42 | -0.13 | -0.79% |
GQG Partners Emerging Markets Equity Inv | |||
NGUAX | 29.64 | -0.59 | -1.95% |
Neuberger Berman Large Cap Growth Inv | |||
FSCVX | 26.26 | -0.53 | -1.98% |
Nuveen Small Cap Value C | |||
OFSFX | 21.39 | -0.52 | -2.37% |
Olstein Strategic Opportunities Adviser |